Screening for Cancer in Patients With Unprovoked VTE

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 650 participants.

Also called NCT03937583

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 650 participants (planned count) (from the registry)
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (from the registry)
Registry
  • NCT NCT03937583
  • EudraCT 2018-003958-25
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03937583. Randomized; no masking; primary purpose diagnostic. Start 2019-10-23 (actual); primary completion 2023-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Screening for Cancer in Patients With Unprovoked VTE
Acronym
SOME-RIETE
Condition
Venous Thromboembolic Disease
Condition
Respiratory Disease
Condition
Pulmonary Disease
Condition
Deep Venous Thrombosis
Condition
Screening
Condition
Undefined
Intervention (Drug)
Fludeoxyglucose 18F
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (class: other)

Record details

Record id
cardio:ct-nct03937583
Content hash
4379ed19246b2761ce36b8471c8b36efaf91c80e5d57bb59735b2a66225c2706